1. Li, Jing, Han, Sufang, Qian, Ziliang, Yu, De-Hua, Ji, Qunsheng. 2013. Genetic amplification of PPME1 in gastric and lung cancer and its potential as a novel therapeutic target. In Cancer biology & therapy, 15, 128-34. doi:10.4161/cbt.27146. https://pubmed.ncbi.nlm.nih.gov/24253382/
2. Handkiewicz-Junak, Daria, Swierniak, Michal, Rusinek, Dagmara, Swierniak, Andrzej, Jarzab, Barbara. 2016. Gene signature of the post-Chernobyl papillary thyroid cancer. In European journal of nuclear medicine and molecular imaging, 43, 1267-77. doi:10.1007/s00259-015-3303-3. https://pubmed.ncbi.nlm.nih.gov/26810418/
3. Labuzan, Sydney A, Lynch, Sarah A, Cooper, Lisa M, Waddell, David S. 2020. Inhibition of protein phosphatase methylesterase 1 dysregulates MAP kinase signaling and attenuates muscle cell differentiation. In Gene, 739, 144515. doi:10.1016/j.gene.2020.144515. https://pubmed.ncbi.nlm.nih.gov/32112987/
4. Kaur, Amanpreet, Elzagheid, Adam, Birkman, Eva-Maria, Westermarck, Jukka, Sundström, Jari. 2015. Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer. In Cancer medicine, 4, 1798-808. doi:10.1002/cam4.541. https://pubmed.ncbi.nlm.nih.gov/26377365/